Would you offer SRS to a hippocampal metastasis in a patient with ES-SCLC treated with prior WBRT?
Would your dose or approach differ if the patient had had prior WBRT, HA-WBRT or not?
Answer from: Radiation Oncologist at Academic Institution
I agree with Dr. @Boukaram. The brain metastasis is a greater risk to the patient than SRS would be. Whether the prior WBRT used hippocampal sparing or not would not change my recommendation.I am not well-versed in neurocognitive anatomy. But it is feasible to injure (or remove) 1 hippocampus and ha...